Sunday, January 4, 2015

Hot Long Term Companies For 2014

When short sellers start circling the wagons, they can drive a stock down and keep it down for quite some time. 

That goes even for a company that has no debt -- and has been consistently increasing shareholders' equity. 

One such company also has high margins and generates impressively high returns on invested capital. Over the past four years, this company has maintained a return on invested capital (ROIC) of 35% or higher. 

This company is Vera Bradley (NYSE: VRA), which, with a short interest of more than 50%, is one of the most shorted stocks in the market. While VRA has more than disappointed investors over the past 12 months, the market could be offering investors a great entry point for the long term.

The short interest in Vera comes as competition in the women's accessories market has been heating up. The success of Michael Kors (NYSE: KORS) over the past year and a half has kept the short interest relatively high at Vera. But Kors appears to be much more of a threat to Coach (NYSE: COH) than to Vera. Rising inventory levels had also managed to catch short sellers' attention. This was a result of too many Vera products flooding the market, but a refocus on strategy should improve inventory management.  

Top 5 Gold Stocks To Invest In Right Now: Titan Pharmaceuticals Inc (TTNP)

Titan Pharmaceuticals, Inc., incorporated in February 1992, is a biopharmaceutical company developing therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of products that include Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders, and Spheramine for the treatment of advanced Parkinson�� disease. Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson�� disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.

Probuphine

Probuphine is the first product to utilize the Company�� ProNeura long-term drug delivery technology. Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid addiction. In December 2007, the Company completed enrollment in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical study of Probuphine in the treatment of opioid addiction. This 150 patient study, which is being conducted in the United States, will evaluate the safety and effectiveness of treatment with Probuphine versus placebo in reducing opioid addiction over 24 weeks of treatment. This study is part of a registration directed program intended to obtain marketing approval of Probuphine for the treatment of opioid addiction in Europe and the United States.

Iloperidone

Iloperidone was evaluated in a Phase III program comprising over 3,500 patients at more than 200 sites in 24 countries, administered and funded by Novartis Pharma AG (Novartis). In three completed efficacy studies conducted by Novartis, ilop! eridone statistically reduced the symptoms of schizophrenia compared to placebo. Iloperidone has also been investigated in three 12-month safety studies, which confirm safety and tolerability. A dose dependent increase in the Q-T Corrected (QTc) interval was observed and investigated further in a clinical study, and no clinically significant adverse events were observed. In September 2007, Vanda submitted a new drug application (NDA) with the United States Food and Drug Administration (FDA) for iloperidone. The NDA for iloperidone was officially accepted for review by the FDA in November 2007.

Spheramine

Spheramine is a cell-based therapeutic that utilizes the Company�� cell-coated microcarrier (CCM) technology, which enables the development of cell-based therapies for minimally invasive, site-specific delivery to the central nervous system of therapeutic factors precisely where they are needed. Spheramine consists of microcarriers coated with human retinal pigment epithelial cells that are intended to enhance brain levels of dopamine, a neurotransmitter deficient in certain brain regions in Parkinson�� disease, leading to movement disorders. Preclinical studies have demonstrated the preliminary efficacy and safety of Spheramine, including blinded studies in a primate model of Parkinson�� disease. In June 2007, enrollment was completed in a current multi-center, randomized, double-blind, placebo-controlled clinical trial of Spheramine in Parkinson�� disease. This Phase IIb clinical study enrolled 71 patients with advanced Parkinson�� disease (Hoehn and Yahr Stages III and IV) to further evaluate the efficacy, safety, and tolerability of Spheramine.

Bayer Schering, the Company�� corporate partner for worldwide development and commercialization of Spheramine, is funding the clinical development program for Spheramine. Under an agreement, Bayer Schering has received exclusive, worldwide development, manufacturing and commercialization rights, and, in ad! dition to! the clinical and manufacturing development funding and milestone payments, Bayer Schering will pay Titan Pharmaceuticals a royalty on future product sales.

Advisors' Opinion:
  • [By CRWE]

    Today, TTNP surged (+2.76%) up +0.018 at $.689 with 152,996 shares in play thus far (ref. google finance Delayed: 2:02PM EDT October 1, 2013).

    Titan Pharmaceuticals, Inc. previously reported that the U.S. Food and Drug Administration (FDA) has granted the request for a meeting to discuss Probuphine庐. The meeting is scheduled for November 19, 2013. The FDA has designated this as a Type C meeting and has requested the submission of briefing materials by October 7, 2013.

Hot Long Term Companies For 2014: ExlService Holdings Inc.(EXLS)

Exlservice Holdings, Inc., together with its subsidiaries, provides outsourcing and transformation services primarily in the United States and the United Kingdom. Its outsourcing services include claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business processing, policy servicing, trades/sub-account transactions, add-on processing, premium audit, billing and collection, and customer services in insurance and healthcare sector; back-office processing for customer operations, metering-related services and billing, debt recovery operations, imbalance management, and account management services in utilities sector; and servicing and processing various banking products, including residential mortgage lending, retail banking, credit cards, consumer finance, commercial lending, and investment management in banking and financial services sector. The company?s outsourcing services also co mprise processing transactions, including supply chain management, warehousing, transloading, transportation management, and international logistics services in transportation and logistics sector; managing and improving operational, financial, and analytical functions for travel management companies; and finance and accounting services, including accounts payable, accounts receivable, inter-company reconciliations, financial and statutory reporting, treasury management, and tax compliance. In addition, it offers transformation services consisting of decision analytics services, including data filtering, organization and synthesis, management information system reporting, trend and variance analysis, statistical and econometric modeling, and economic and financial markets research; finance transformation services; and operations and process excellence services. The company was founded in 1999 and is headquartered in New York, New York.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Exlservice Holdings (Nasdaq: EXLS  ) , whose recent revenue and earnings are plotted below.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Exlservice Holdings (Nasdaq: EXLS  ) , whose recent revenue and earnings are plotted below.

Hot Long Term Companies For 2014: Emergent Biosolutions Inc. (EBS)

Emergent BioSolutions, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and commercialization of specialized products for use in defense and commercial markets in the United States and internationally. The company operates in two segments, Biodefense and Biosciences. It markets BioThrax, an FDA licensed vaccine for the prevention of anthrax disease; and RSDL (decontamination lotion) product for removal or neutralization of chemical warfare agents from the skin. The company�s development pipeline includes Anthrivig (Human Anthrax Immunoglobulin), a polyclonal anthrax therapeutic candidate; PreviThrax, a recombinant anthrax vaccine candidate, NuThrax (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant); BioThrax with a novel adjuvant; and Thravixa (Fully Human Anthrax Monoclonal Antibody), a therapeutic being studied for use against symptomatic anthrax infection. In addition, it develops TRU-016, a humanized anti-CD37 therapeutic candidate, ba sed on its ADAPTIR (Modular Protein Technology) platform that is in Phase I/II clinical trials to treat chronic lymphocytic leukemia. Further, the company develops preclinical product candidates targeted for solid tumors, inflammatory bowel disease, graft versus host disease, rheumatoid arthritis, and a human vaccine to protect against influenza caused by a range of circulating H5 influenza strains. Emergent BioSolutions, Inc. was founded in 1998 and is headquartered in Rockville, Maryland.

Advisors' Opinion:
  • [By Stephen Quickel]

    Emergent BioSolutions (EBS) is a far smaller specialist in bio-medical products for the military and commercial markets, including anthrax vaccine and decontamination agents. With revenues nearing $400 million, EBS is acquiring Canada's Cangene Corp. to expand its product line.

  • [By Traders Reserve]

    I discovered Emergent Bio Solutions (EBS) when I ran my proprietary P/E Gap model at the end of December. Without getting into the details, P/E Gap identifies stocks that have the potential to rally based on being significantly undervalued.

Hot Long Term Companies For 2014: Avalon Holdings Corp (AWX)

Avalon Holdings Corporation (Avalon) is a subsidiary of American Waste Services, Inc. (AWS). Avalon operates in two business segments: waste management services and golf and related operations. The waste management services segment includes waste disposal brokerage and management services and captive landfill management operations. The golf and related operations segment includes the operation and management of golf courses, fitness centers, tennis, spa services, dining and banquet facilities and a travel agency. During the year ended December 31, 2011, the net operating revenues of the waste management services segment represented approximately 81% of its total segments��net operating revenues. During 2011, the net operating revenues of the golf and related operations segment represented approximately 19% of its total segments��net operating revenues.

Waste Management Services

Avalon�� waste management subsidiaries provide hazardous and nonhazardous waste brokerage and management services and captive landfill management services. Waste management services are provided to industrial, commercial, municipal and governmental customers primarily in selected north-eastern and mid-western United States markets. American Waste Management Services, Inc. (AWMS) assists customers with managing and disposing of wastes at approved treatment and disposal sites based upon a customer�� needs. American Landfill Management, Inc. (ALMI) is a landfill management company that provides technical and operational services to customers owning captive disposal facilities. A captive disposal facility only disposes of waste generated by the owner of such facility. ALMI provides turnkey services, including daily operations, facilities management and management reporting for its customers. As of December 31, 2011, ALMI manages one captive disposal facility located in Ohio. In addition, American Construction Supply, Inc., a wholly owned subsidiary of ALMI, sells construction mats.

Gol! f and Related Operations

Avalon�� golf and related operations segment operates golf courses and related facilities and a travel agency. Avalon Lakes Golf, Inc. (ALGI) owns and operates a Pete Dye designed championship golf course located in Warren, Ohio. ALGI generates revenue from membership dues, greens fees, cart rentals, merchandise, and food and beverage sales. TBG, Inc. (TBG), a subsidiary of ALGI, entered into a long-term agreement with Squaw Creek Country Club to lease and operate its golf course and related facilities. In addition to a championship golf course, the Squaw Creek facilities include a swimming pool, tennis courts and a clubhouse that includes a fitness center, dining and banquet facilities. TBG generates its revenue in the same manner as ALGI, but also generates revenues from tennis. Avalon Travel, Inc., a subsidiary of ALGI, owns and operates a travel agency which generates its revenue from booking travel reservations. Avalon�� golf courses are located in Warren, Ohio, Vienna, Ohio and Sharon, Pennsylvania.

Advisors' Opinion:
  • [By Geoff Gannon] company that is in two different businesses.

    It has a golf course business that is not profitable but has a lot of assets. And then it has a waste management business that is profitable. But doesn�� have a lot of assets.

    This is the sort of situation where I would pay a lot of attention to the balance sheet. You aren�� really double counting in a stock like this. The assets are not producing the earnings. They could be separated from the business.

    Unfortunately, this is a controlled company. And not a good activist target.

    But you will find situations like Gyrodyne (GYRO) and Syms (SYMSQ) where at some point the company�� entire value really depended on its balance sheet.

    Obviously when looking at things like real estate you don�� go by what it says on the balance sheet. You try to find a note on depreciation that breaks out land, buildings, etc. And gives information about how the company depreciates its property.

    And ��of course ��you look at the ��roperties��item in the 10-K. In the U.S., you then use the information you��e gathered to check county land records and things like that for more information about the property.

    Generally, you want to:

    路 Find out when the company bought the property

Hot Long Term Companies For 2014: Ardonblue Ventures Inc (ARB)

Ardonblue Ventures Inc., formerly August Metal Corporation, is a Canada-based company engaged in the business of acquiring, exploring and evaluating mineral resource properties. Las Lajas Project consists of approximately seven contiguous mining concessions and is located in Southern Sonora State, Mexico. The concessions are owned by Minera Goldzone SA de CV a wholly owned subsidiary of Goldzone Exploration Inc. Las Lajas has access and infrastructure as it is located approximately 15 kilometers north of the city of Navojoa. The Thurlow Property occupies the central part of the Doratha Morton gold trend, located on British Columbia�� southwestern coast near Phillips Arm. The Property consists of approximately nine crown granted mineral claims covering a total of approximately 142.61hectares. Advisors' Opinion:
  • [By Rich Duprey]

    International media and marketing shop Arbitron� (NYSE: ARB  ) �announced yesterday�its second-quarter dividend of $0.10 per share, the same rate it's always paid since 2005

Hot Long Term Companies For 2014: B P Marsh and Partners PLC (BPM)

B. P. Marsh & Partners PLC is a United Kingdom-based specialist private equity investor in early stage financial services businesses. The Firm considers investments opportunities based in the United Kingdom, Europe, North America and occasionally elsewhere. The Firm has invested in over 25 financial service businesses since it was founded in 1990 and in February 2006 admitted its shares for trading on the Alternative Investment Market. It typically invest amounts of up to EURO 2.5 million in people businesses. Some of its portfolio companies include: The Broucour Group Limited, LEBC Holdings Limited, Hyperion Insurance Group Limited, and Paterson Squared LLC. In June 2013, it sold 80% of its holding in Hyperion to General Atlantic Hawthorn B.V. Advisors' Opinion:
  • [By Robert Abbott]

    For OTEX, this includes five distinct groups of services:

    Enterprise Content Management (ECM), which includes records management, archiving, and email services Business Process Management (BPM), including software for analyzing and optimizing business processes Customer Experience Management (CEM), includes software that integrates internal and external content to enhance the ��ustomer experience�� Information Exchange (iX), "...a set of offerings that facilitate efficient, secure, and compliant exchange of information inside and outside the enterprise." Discovery, which includes the indexing, navigation, and retrieval of information in databases (for a fuller description of these segments, see the 10-K Report for 2014).

    As of June 30, 2014 it employed about 8,000, including 2,000 in cloud services, 1,900 in product development and 1,400 in sales and marketing.

No comments:

Post a Comment